Diabeteksen munuaistauti, näytönastekatsausten kirjallisuusviitteet
Lisätietoa aiheesta
Käypä hoito -toimitus
20.4.2020
Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Diabeteksen
munuaistauti «Diabeteksen munuaistauti»1 näytönastekatsauksissa arvioitu kirjallisuus.
Kirjallisuutta
- Adler AI, Stevens RJ, Manley SE ym. Development and progression of nephropathy in
type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney
Int 2003;63:225-32 «PMID: 12472787»PubMed
- Agrawal L, Azad N, Bahn GD ym. Long-term follow-up of intensive glycaemic control
on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetologia 2018;61:295-299
«PMID: 29101421»PubMed
- Baggio B, Budakovic A, Dalla Vestra M ym. Effects of cigarette smoking on glomerular
structure and function in type 2 diabetic patients. J Am Soc Nephrol 2002;13:2730-6
«PMID: 12397043»PubMed
- Baigent C, Landray MJ, Reith C ym. The effects of lowering LDL cholesterol with simvastatin
plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection):
a randomised placebo-controlled trial. Lancet 2011;377:2181-92 «PMID: 21663949»PubMed
- Bakker AJ. Detection of microalbuminuria. Receiver operating characteristic curve
analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care
1999;22:307-13 «PMID: 10333950»PubMed
- Bakris GL, Williams M, Dworkin L ym. Preserving renal function in adults with hypertension
and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes
Executive Committees Working Group. Am J Kidney Dis 2000;36:646-61 «PMID: 10977801»PubMed
- Billeter AT, Scheurlen KM, Probst P ym. Meta-analysis of metabolic surgery versus
medical treatment for microvascular complications in patients with type 2 diabetes
mellitus. Br J Surg 2018;105:168-181 «PMID: 29405276»PubMed
- Brenner BM, Cooper ME, de Zeeuw D ym. Effects of losartan on renal and cardiovascular
outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9
«PMID: 11565518»PubMed
- Cases A, Coll E. Dyslipidemia and the progression of renal disease in chronic renal
failure patients. Kidney Int Suppl 2005;:S87-93 «PMID: 16336584»PubMed
- Chase HP, Garg SK, Marshall G ym. Cigarette smoking increases the risk of albuminuria
among subjects with type I diabetes. JAMA 1991;265:614-7 «PMID: 1987411»PubMed
- Chen Y, Zhi Y, Li C ym. HDL cholesterol and risk of diabetic nephropathy in patient
with type 1 diabetes: A meta-analysis of cohort studies. Diabetes Res Clin Pract 2016;122:84-91
«PMID: 27816683»PubMed
- Chronic Kidney Disease Prognosis Consortium., Matsushita K, van der Velde M ym. Association
of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular
mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-81
«PMID: 20483451»PubMed
- Chuahirun T, Simoni J, Hudson C ym. Cigarette smoking exacerbates and its cessation
ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004;327:57-67 «PMID: 14770020»PubMed
- de Boer IH, Gao X, Cleary PA ym. Albuminuria Changes and Cardiovascular and Renal
Outcomes in Type 1 Diabetes: The DCCT/EDIC Study. Clin J Am Soc Nephrol 2016;11:1969-1977
«PMID: 27797889»PubMed
- Diabetes Control and Complications Trial Research Group., Nathan DM, Genuth S ym.
The effect of intensive treatment of diabetes on the development and progression of
long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
«PMID: 8366922»PubMed
- Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent
diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-8
«PMID: 9224218»PubMed
- Dwyer JP, Parving HH, Hunsicker LG ym. Renal Dysfunction in the Presence of Normoalbuminuria
in Type 2 Diabetes: Results from the DEMAND Study. Cardiorenal Med 2012;2:1-10 «PMID: 22493597»PubMed
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes
mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention
Evaluation Study Investigators. Lancet 2000;355:253-9 «PMID: 10675071»PubMed
- Feodoroff M, Harjutsalo V, Forsblom C ym. Smoking and progression of diabetic nephropathy
in patients with type 1 diabetes. Acta Diabetol 2016;53:525-33 «PMID: 26668013»PubMed
- Gaede P, Vedel P, Larsen N ym. Multifactorial intervention and cardiovascular disease
in patients with type 2 diabetes. N Engl J Med 2003;348:383-93 «PMID: 12556541»PubMed
- Gall MA, Borch-Johnsen K, Hougaard P ym. Albuminuria and poor glycemic control predict
mortality in NIDDM. Diabetes 1995;44:1303-9 «PMID: 7589828»PubMed
- Gansevoort RT, Verhave JC, Hillege HL ym. The validity of screening based on spot
morning urine samples to detect subjects with microalbuminuria in the general population.
Kidney Int Suppl 2005;:S28-35 «PMID: 15752236»PubMed
- Gerstein HC, Mann JF, Yi Q ym. Albuminuria and risk of cardiovascular events, death,
and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6 «PMID: 11466120»PubMed
- Gozzoli V, Palmer AJ, Brandt A ym. [Increased clinical and economic advantages using
PROSIT (proteinuria screening and intervention) in type 2 diabetic patients]. Dtsch
Med Wochenschr 2000;125:1154-9 «PMID: 11075242»PubMed
- Groop PH, Thomas MC, Moran JL ym. The presence and severity of chronic kidney disease
predicts all-cause mortality in type 1 diabetes. Diabetes 2009;58:1651-8 «PMID: 19401416»PubMed
- Holman RR, Paul SK, Bethel MA ym. 10-year follow-up of intensive glucose control in
type 2 diabetes. N Engl J Med 2008;359:1577-89 «PMID: 18784090»PubMed
- Houlihan CA, Tsalamandris C, Akdeniz A ym. Albumin to creatinine ratio: a screening
test with limitations. Am J Kidney Dis 2002;39:1183-9 «PMID: 12046029»PubMed
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK
Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53 «PMID: 9742976»PubMed
- Jansson FJ, Forsblom C, Harjutsalo V ym. Regression of albuminuria and its association
with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane
Study. Diabetologia 2018;61:1203-1211 «PMID: 29423580»PubMed
- Koye DN, Magliano DJ, Reid CM ym. Risk of Progression of Nonalbuminuric CKD to End-Stage
Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort)
Study. Am J Kidney Dis 2018;72:653-661 «PMID: 29784612»PubMed
- Kramer HJ, Nguyen QD, Curhan G ym. Renal insufficiency in the absence of albuminuria
and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003;289:3273-7 «PMID: 12824208»PubMed
- Lewis EJ, Hunsicker LG, Bain RP ym. The effect of angiotensin-converting-enzyme inhibition
on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62
«PMID: 8413456»PubMed
- Lewis EJ, Hunsicker LG, Clarke WR ym. Renoprotective effect of the angiotensin-receptor
antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl
J Med 2001;345:851-60 «PMID: 11565517»PubMed
- MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM.
Diabetologia 1995;38:610-6 «PMID: 7489846»PubMed
- Mann JFE, Ørsted DD, Brown-Frandsen K ym. Liraglutide and Renal Outcomes in Type 2
Diabetes. N Engl J Med 2017;377:839-848 «PMID: 28854085»PubMed
- Marso SP, Bain SC, Consoli A ym. Semaglutide and Cardiovascular Outcomes in Patients
with Type 2 Diabetes. N Engl J Med 2016;375:1834-1844 «PMID: 27633186»PubMed
- Metsärinne K, Bröijersen A, Kantola I ym. High prevalence of chronic kidney disease
in Finnish patients with type 2 diabetes treated in primary care. Prim Care Diabetes
2015;9:31-8 «PMID: 25066820»PubMed
- Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in
maturity-onset diabetes. N Engl J Med 1984;310:356-60 «PMID: 6690964»PubMed
- Nathan DM, Cleary PA, Backlund JY ym. Intensive diabetes treatment and cardiovascular
disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53 «PMID: 16371630»PubMed
- Newman DJ, Mattock MB, Dawnay AB ym. Systematic review on urine albumin testing for
early detection of diabetic complications. Health Technol Assess 2005;9:iii-vi, xiii-163
«PMID: 16095545»PubMed
- O'Brien R, Johnson E, Haneuse S ym. Microvascular Outcomes in Patients With Diabetes
After Bariatric Surgery Versus Usual Care: A Matched Cohort Study. Ann Intern Med
2018;169:300-310 «PMID: 30083761»PubMed
- Oellgaard J, Gæde P, Rossing P ym. Reduced risk of heart failure with intensified
multifactorial intervention in individuals with type 2 diabetes and microalbuminuria:
21 years of follow-up in the randomised Steno-2 study. Diabetologia 2018;61:1724-1733
«PMID: 29850922»PubMed
- Packham DK, Alves TP, Dwyer JP ym. Relative incidence of ESRD versus cardiovascular
mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC
(Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am J Kidney
Dis 2012;59:75-83 «PMID: 22051245»PubMed
- Palmer SC, Navaneethan SD, Craig JC ym. HMG CoA reductase inhibitors (statins) for
people with chronic kidney disease not requiring dialysis. Cochrane Database Syst
Rev 2014;:CD007784 «PMID: 24880031»PubMed
- Parving HH, Lehnert H, Bröchner-Mortensen J ym. The effect of irbesartan on the development
of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-8
«PMID: 11565519»PubMed
- Penno G, Solini A, Bonora E ym. Clinical significance of nonalbuminuric renal impairment
in type 2 diabetes. J Hypertens 2011;29:1802-9 «PMID: 21738053»PubMed
- Penno G, Solini A, Bonora E ym. Defining the contribution of chronic kidney disease
to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And
Cardiovascular Events (RIACE) Italian Multicenter Study. Acta Diabetol 2018;55:603-612
«PMID: 29574497»PubMed
- Penno G, Solini A, Orsi E ym. Non-albuminuric renal impairment is a strong predictor
of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular
Events (RIACE) Italian multicentre study. Diabetologia 2018;61:2277-2289 «PMID: 30032426»PubMed
- Perkins BA, Ficociello LH, Roshan B ym. In patients with type 1 diabetes and new-onset
microalbuminuria the development of advanced chronic kidney disease may not require
progression to proteinuria. Kidney Int 2010;77:57-64 «PMID: 19847154»PubMed
- Perkovic V, de Zeeuw D, Mahaffey KW ym. Canagliflozin and renal outcomes in type 2
diabetes: results from the CANVAS Program randomised clinical trials. Lancet Diabetes
Endocrinol 2018;6:691-704 «PMID: 29937267»PubMed
- Persson F, Lindhardt M, Rossing P ym. Prevention of microalbuminuria using early intervention
with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic
review. J Renin Angiotensin Aldosterone Syst 2016;17: «PMID: 27488274»PubMed
- Pfeffer MA, Claggett B, Diaz R ym. Lixisenatide in Patients with Type 2 Diabetes and
Acute Coronary Syndrome. N Engl J Med 2015;373:2247-57 «PMID: 26630143»PubMed
- Rahman M, Baimbridge C, Davis BR ym. Progression of kidney disease in moderately hypercholesterolemic,
hypertensive patients randomized to pravastatin versus usual care: a report from the
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Am J Kidney Dis 2008;52:412-24 «PMID: 18676075»PubMed
- Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and
Complications Research Group., Lachin JM, Genuth S ym. Retinopathy and nephropathy
in patients with type 1 diabetes four years after a trial of intensive therapy. N
Engl J Med 2000;342:381-9 «PMID: 10666428»PubMed
- Retnakaran R, Cull CA, Thorne KI ym. Risk factors for renal dysfunction in type 2
diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006;55:1832-9 «PMID: 16731850»PubMed
- Rodríguez-Gutiérrez R, Montori VM. Glycemic Control for Patients With Type 2 Diabetes
Mellitus: Our Evolving Faith in the Face of Evidence. Circ Cardiovasc Qual Outcomes
2016;9(5):504-12
- Ruggenenti P, Fassi A, Ilieva AP ym. Preventing microalbuminuria in type 2 diabetes.
N Engl J Med 2004;351:1941-51 «PMID: 15516697»PubMed
- Ruggenenti P, Porrini E, Motterlini N ym. Measurable urinary albumin predicts cardiovascular
risk among normoalbuminuric patients with type 2 diabetes. J Am Soc Nephrol 2012;23:1717-24
«PMID: 22935482»PubMed
- Ruospo M, Saglimbene VM, Palmer SC ym. Glucose targets for preventing diabetic kidney
disease and its progression. Cochrane Database Syst Rev 2017;6:CD010137 «PMID: 28594069»PubMed
- Sawicki PT, Didjurgeit U, Mühlhauser I ym. Smoking is associated with progression
of diabetic nephropathy. Diabetes Care 1994;17:126-31 «PMID: 8137682»PubMed
- Targher G, Zoppini G, Chonchol M ym. Glomerular filtration rate, albuminuria and risk
of cardiovascular and all-cause mortality in type 2 diabetic individuals. Nutr Metab
Cardiovasc Dis 2011;21:294-301 «PMID: 20096544»PubMed
- Diabetes Control and Complications Trial Research Group., Nathan DM, Genuth S ym.
The effect of intensive treatment of diabetes on the development and progression of
long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
«PMID: 8366922»PubMed
- Thomas MC, Macisaac RJ, Jerums G ym. Nonalbuminuric renal impairment in type 2 diabetic
patients and in the general population (national evaluation of the frequency of renal
impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009;32:1497-502 «PMID: 19470839»PubMed
- Thorn LM, Gordin D, Harjutsalo V ym. The Presence and Consequence of Nonalbuminuric
Chronic Kidney Disease in Patients With Type 1 Diabetes. Diabetes Care 2015;38:2128-33
«PMID: 26310691»PubMed
- Tight blood pressure control and risk of macrovascular and microvascular complications
in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13
«PMID: 9732337»PubMed
- Wanner C, Inzucchi SE, Lachin JM ym. Empagliflozin and Progression of Kidney Disease
in Type 2 Diabetes. N Engl J Med 2016;375:323-34 «PMID: 27299675»PubMed
- Wiviott SD, Raz I, Bonaca MP ym. Dapagliflozin and Cardiovascular Outcomes in Type
2 Diabetes. N Engl J Med 2019;380:347-357 «PMID: 30415602»PubMed
- Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes
Interventions and Complications Research Group. Sustained effect of intensive treatment
of type 1 diabetes mellitus on development and progression of diabetic nephropathy:
the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-67
- Wu HY, Peng YS, Chiang CK ym. Diagnostic performance of random urine samples using
albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening
in patients with diabetes mellitus: a systematic review and meta-analysis. JAMA Intern
Med 2014;174:1108-15 «PMID: 24798807»PubMed
- Zelniker TA, Wiviott SD, Raz I ym. SGLT2 inhibitors for primary and secondary prevention
of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis
of cardiovascular outcome trials. Lancet 2019;393:31-39 «PMID: 30424892»PubMed
- Zhu HG, Jiang ZS, Gong PY ym. Efficacy of low-protein diet for diabetic nephropathy:
a systematic review of randomized controlled trials. Lipids Health Dis 2018;17:141
«PMID: 29914534»PubMed
- Zoungas S, Arima H, Gerstein HC ym. Effects of intensive glucose control on microvascular
outcomes in patients with type 2 diabetes: a meta-analysis of individual participant
data from randomised controlled trials. Lancet Diabetes Endocrinol 2017;5:431-437
«PMID: 28365411»PubMed
Artikkelin tunnus: nix02785 (050.060)
© 2025 Suomalainen Lääkäriseura Duodecim